Beirne Wealth Consulting Services’s AbbVie ABBV Stock Holding History

Beirne Wealth Consulting Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,754	Closed	-$638K	–	108
2025 Q3	$638K	Buy	2,754 +1,580	+135%	+$322K	0.15%	87
2025 Q2	$218K	Hold	1,174	–	–	0.07%	95
2025 Q1	$246K	Hold	1,174	–	–	0.09%	85
2024 Q4	$209K	Hold	1,174	–	–	0.08%	90
2024 Q3	$232K	Hold	1,174	–	–	0.08%	89
2024 Q2	$201K	Sell	1,174 -43	-4%	-$7.12K	0.08%	93
2024 Q1	$222K	Sell	1,217 -1,451	-54%	-$250K	0.09%	88
2023 Q4	$414K	Buy	+2,668	New	+$389K	0.2%	83
2023 Q1	–	Sell	-1,284	Closed	-$208K	–	100
2022 Q4	$208K	Buy	+1,284	New	+$197K	0.1%	83
2022 Q2	–	Sell	-1,284	Closed	-$208K	–	95
2022 Q1	$208K	Buy	+1,284	New	+$187K	0.12%	88
2021 Q1	–	Sell	-2,000	Closed	-$214K	–	110
2020 Q4	$214K	Buy	+2,000	New	+$192K	0.11%	144

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Beirne Wealth Consulting Services's ABBV Position: Q4 2025 in Review

Beirne Wealth Consulting Services sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 2,754 shares — an estimated $638K sold.

Beirne Wealth Consulting Services first reported a position in ABBV in Q4 2020 and held it in 11 quarters. The position peaked at $638K in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Beirne Wealth Consulting Services reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Beirne Wealth Consulting Services sold 2,754 AbbVie shares in Q4 2025, an estimated $638K.
Beirne Wealth Consulting Services first reported a position in AbbVie in Q4 2020 and held it in 11 quarters.
Beirne Wealth Consulting Services's AbbVie position peaked at $638K in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Beirne Wealth Consulting Services's 13F filing for Q4 2025, filed 29 Jan 2026.